RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+36.95%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$777M
AUM Growth
+$777M
(+25%)
Cap. Flow
-$2.93M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
67.53%
Holding
55
New
12
Increased
4
Reduced
8
Closed
7
Top Buys
| 1 |
RGLS
Regulus Therapeutics
RGLS
|
$76.1M |
| 2 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$25.4M |
| 3 |
TG Therapeutics
TGTX
|
$20.4M |
| 4 |
FWP
Forward Pharma A/S American Depositary Shares
FWP
|
$20.2M |
| 5 |
TRVN
Trevena, Inc.
TRVN
|
$17.8M |
Top Sells
| 1 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$64.2M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
$40.3M |
| 3 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$34.8M |
| 4 |
BLUE
bluebird bio
BLUE
|
$20.4M |
| 5 |
Dynavax Technologies
DVAX
|
$17.4M |
Sector Composition
| 1 | Healthcare | 77.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Enanta Pharmaceuticals
ENTA
$189M
| – | – |
-250,000
| Closed | -$9.89M |
|
52
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-9,300
| Closed | -$1.04M |
|
|
VIRX
53
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-23,187
| Closed | -$34.8M |
|
|
ALIM
54
DELISTED
Alimera Sciences, Inc.
ALIM
| – | – |
-16,248
| Closed | -$1.32M |
|
|
AVNR
55
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| – | – |
-5,386,700
| Closed | -$64.2M |
|